Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ASND Ascendis Pharma A/S
116.100-1.640-1.39%
Close
02/03 16:00 ET
116.1000.0000.00%
Post Mkt Price 02/03 16:35 ET
High
119.480
Open
116.890
Turnover
14.80M
Low
115.080
Pre Close
117.740
Volume
126.97K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
First Republic Investment Management Inc. Raises Stock Position in Ascendis Pharma A/S (NASDAQ:ASND)
First Republic Investment Management Inc. boosted its holdings in Ascendis Pharma A/S (NASDAQ:ASND – Get Rating) by 17.3% in the third quarter, according to its most recent filing with the SEC. The
Ascendant Resources Brief: Announcing High Grade Copper Assay Results Supporting High-Grade Copper Corridor at the Venda Nova South Zone
Ascendant Resources Says Engaged Decarbonization Consultant to Drive Carbon Neutrality at Lagoa Salgada
06:31 AM EST, 01/23/2023 (MT Newswires) -- Ascendant Resources Inc. (ASND.TO) on Monday said it has engaged Synergy Enterprises, a firm that specializes in greenhouse gas accounting and decarbonizatio
Tech Stocks Lead European Equities Modestly Higher in Wednesday Trading
11:09 AM EST, 01/18/2023 (MT Newswires) -- Tech stocks are helping lead European equities modestly higher in Wednesday trading as American depositary receipts of European stocks rose 0.52% to 1,177.35
Ascendant Resources Starts Drilling "Anomaly D" Exploration Target at Lagoa Salgada in Portugal
07:26 AM EST, 01/18/2023 (MT Newswires) -- Ascendant Resources Inc. (ASND.TO) said Wednesday it has started its 5,000-meter regional exploration program, designed to drill two highly prospective geoph
Ascendis Pharma Is Maintained at Outperform by SVB Leerink
Ascendis Pharma Is Maintained at Outperform by SVB Leerink
Ascendis Pharma Price Target Raised to $163.00/Share From $148.00 by SVB Leerink
SVB Leerink Maintains Outperform on Ascendis Pharma, Raises Price Target to $163
SVB Leerink analyst Joseph Schwartz maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and raises the price target from $148 to $163.
European Equities Begin Week With Sharp Rise
11:20 AM EST, 01/09/2023 (MT Newswires) -- European equities started the week on a strong note and moved sharply higher in Monday trading as American depositary receipts of European stocks rose 1.4% t
Ascendis Pharma's (NASDAQ:ASND) Growing Losses Don't Faze Investors as the Stock Climbs 3.8% This Past Week
Company Overview
More
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
CEO： Mr. Jan Moller Mikkelsen
Market： NASDAQ
Listing Date： 01/28/2015
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet